Skip to content

RG+A

  • About Us
    • RG+A Customer Creed
    • Culture
    • Our Core Values
    • Senior Staff
      • Roger Green
      • Kevin M. Kelly
      • Tim Deckman, Ph.D.
      • Ellen J. Gordon, Ph.D.
      • Bruce Duncan, Ph.D.
      • Joan L. Lorgus
      • Kim Kurtin
    • Testimonials
  • Our Work
    • Our Experience
      • Treatment Areas and Therapeutic Drug Classes
    • Expert Insights
      • Enhancing forecast precision by simulating patient treatments
      • Abandoned by Nielsen? RG+A can help you now!
      • Webinar: Forecasting Across Lines of Therapy
      • Presentation: Forecast Treatment across Multiple Therapy Lines
      • Managed Care’s Perspective: Best Practices in Payer-Manufacturer Relationships
      • Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
      • Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
      • Better Answers with Imprecise Data
      • Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
    • Case Studies
      • Product Positioning for an Innovative In-Home Medical Device
      • Hazardous Drug Detection for Employee Safety
      • Assessing Market Potential and Development Strategy
      • Pricing and Volumetric Forecasting for an Orphan Drug
      • Using DPS®/Conjoint to Formulate a Competitive Response
      • Forecasting for Multiple Indications within the ADHD Market
      • Generic Competition Assessment Among Payers Using PV Scope®
      • Using Co-Creation with Payers to Support Optimal Product Profile Development and Clinical Trial Design
      • Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
      • Developing Competitive Contracting Strategies using Contract Simulation®
      • Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
      • Forecasting and Strategy Development for a Neurological Product
      • Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
    • Conference Presentations
  • Areas of Expertise
    • Strategic Risk Modeling
    • Forecasting
    • Market Access
    • Pricing
    • Product Development & Positioning
    • Business Development and Licensing
    • Oncology Tools
    • Orphan and Ultra-Orphan Tools
    • Payer Tools
      • Health Payer Council® (HPC®)
  • Methodologies
    • Dynamic Practice Simulation® (DPS®)
      • DPS®/Conjoint
      • Dynamic Practice Simulation® Line of Therapy
    • Qualitative-to-Modeling® (QTM®)
    • Qualitative Conjoint
    • PV Scope
    • Payer Scope
    • Consumer Cascade
    • Health Payer Insights (HPI)
    • Co-creation
    • Contract Simulation®
    • Wisdom of Crowds
  • News
    • RG+A News
    • Health Payer Council® News
    • Blog
    • Upcoming Conferences
  • Contact
    • Join our Mailing List
  • Careers

Senior Staff

  • RG+A Customer Creed
  • Culture
  • Our Core Values
  • Senior Staff
    • Roger Green
      President and CEO
    • Kevin M. Kelly
      Executive Vice President & Chief Operating Officer
    • Tim Deckman, Ph.D.
      Vice President, Chief Marketing Scientist
    • Ellen J. Gordon, Ph.D.
      Senior Vice President and Head of Research
    • Bruce Duncan, Ph.D.
      Executive Vice President & Chief Marketing Scientist Emeritus
    • Joan L. Lorgus
      Vice President-Client Development
    • Kim Kurtin
      Vice President-Client Development
  • Testimonials

  • Roger Green President and CEO

  • Kevin M. Kelly Executive Vice President and Chief Operating Officer

  • Tim Deckman, Ph.D. Vice President and Chief Marketing Scientist

  • Ellen J. Gordon, Ph.D. Senior Vice President and Head of Research

  • Bruce Duncan, Ph.D. Executive Vice President and Chief Marketing Scientist Emeritus

  • Joan L. Lorgus Vice President - Client Development

  • Kim Kurtin Vice President - Client Development

  • About Us
    • RG+A Customer Creed
    • Culture
    • Our Core Values
    • Senior Staff
      • Roger Green
      • Kevin M. Kelly
      • Tim Deckman, Ph.D.
      • Ellen J. Gordon, Ph.D.
      • Bruce Duncan, Ph.D.
      • Joan L. Lorgus
      • Kim Kurtin
    • Testimonials
  • Our Work
    • Our Experience
      • Treatment Areas and Therapeutic Drug Classes
    • Expert Insights
      • Enhancing forecast precision by simulating patient treatments
      • Abandoned by Nielsen? RG+A can help you now!
      • Webinar: Forecasting Across Lines of Therapy
      • Presentation: Forecast Treatment across Multiple Therapy Lines
      • Managed Care’s Perspective: Best Practices in Payer-Manufacturer Relationships
      • Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
      • Forecasting Physician Treatment Decisions across Multiple Lines of Therapy
      • Better Answers with Imprecise Data
      • Attribute Importance Ratings: Are We Learning Anything We Don’t Already Know?
    • Case Studies
      • Product Positioning for an Innovative In-Home Medical Device
      • Hazardous Drug Detection for Employee Safety
      • Assessing Market Potential and Development Strategy
      • Pricing and Volumetric Forecasting for an Orphan Drug
      • Using DPS®/Conjoint to Formulate a Competitive Response
      • Forecasting for Multiple Indications within the ADHD Market
      • Generic Competition Assessment Among Payers Using PV Scope®
      • Using Co-Creation with Payers to Support Optimal Product Profile Development and Clinical Trial Design
      • Applying Dynamic Practice Simulation (DPS) to Development and Commercialization Strategy
      • Developing Competitive Contracting Strategies using Contract Simulation®
      • Contracting Strategy Development using Qualitative Conjoint to Segment Community Oncology Practice Managers
      • Forecasting and Strategy Development for a Neurological Product
      • Feature Optimization via Qualitative Conjoint to Combat Competitive Threat in the Vascular Device Space
    • Conference Presentations
  • Areas of Expertise
    • Strategic Risk Modeling
    • Forecasting
    • Market Access
    • Pricing
    • Product Development & Positioning
    • Business Development and Licensing
    • Oncology Tools
    • Orphan and Ultra-Orphan Tools
    • Payer Tools
      • Health Payer Council® (HPC®)
  • Methodologies
    • Dynamic Practice Simulation® (DPS®)
      • DPS®/Conjoint
      • Dynamic Practice Simulation® Line of Therapy
    • Qualitative-to-Modeling® (QTM®)
    • Qualitative Conjoint
    • PV Scope
    • Payer Scope
    • Consumer Cascade
    • Health Payer Insights (HPI)
    • Co-creation
    • Contract Simulation®
    • Wisdom of Crowds
  • News
    • RG+A News
    • Health Payer Council® News
    • Blog
    • Upcoming Conferences
  • Contact
    • Join our Mailing List
  • Careers

RG+A
480 Union Square Drive
New Hope, PA 18938

Directions

Phone: (267) 744-6400
Fax: (267) 744-6499

Contact Us

Proud members of:

Insights Association PMRG
Copyright © 2018 Roger Green and Associates, Inc. All rights reserved.